Bronconex Acticap

देश: न्यूज़ीलैंड

भाषा: अंग्रेज़ी

स्रोत: Medsafe (Medicines Safety Authority)

सक्रिय संघटक:

Mometasone furoate 400ug (anhydrous)

थमां उपलब्ध:

Organon (New Zealand) Limited

INN (इंटरनेशनल नाम):

Mometasone furoate 400 µg (anhydrous)

डोज़:

400 mcg/dose

फार्मास्यूटिकल फॉर्म:

Powder for inhalation

रचना:

Active: Mometasone furoate 400ug (anhydrous) Excipient: Lactose

पैकेज में यूनिट:

Inhaler, metered, DPI, (sample), 14 dose units

वर्ग:

Prescription

प्रिस्क्रिप्शन प्रकार:

Prescription

द्वारा बनाया गया:

MSD International GmbH (Singapore Branch)

चिकित्सीय संकेत:

Bronconex Acticap is indicated for prophylactic therapy in the management of patients with asthma of all severities, including patients who have been dependent upon either inhaled or systemically administered corticosteroids and non-corticosteroid-dependent patients inadequately controlled on other drug regimens.

उत्पाद समीक्षा:

Package - Contents - Shelf Life: Inhaler, metered, DPI, (sample) - 14 dose units - 18 months from date of manufacture stored at or below 25°C - Inhaler, metered, DPI - 30 dose units - 18 months from date of manufacture stored at or below 25°C - Inhaler, metered, DPI - 60 dose units - 18 months from date of manufacture stored at or below 25°C

प्राधिकरण की तारीख:

2000-12-05